Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging

Blood

Volumn 101, Issue 2, 2003, Pages 640-648

  Edinger, Matthias ^a   Cao, Yu An ^a   Verneris, Michael R ^a   Bachmann, Michael H ^a   Contag, Christopher H ^a   Negrin, Robert S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GREEN FLUORESCENT PROTEIN; TUMOR MARKER; YELLOW FLUORESCENT PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; BONE MARROW TRANSPLANTATION; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CELL SELECTION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; EFFECTOR CELL; FEMALE; FLUORESCENCE; FUSION GENE; IMMUNOCOMPETENT CELL; IN VIVO STUDY; LYMPHOCYTE MIGRATION; LYMPHOMA; LYMPHOMA CELL LINE; METASTASIS; MINIMAL RESIDUAL DISEASE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPORTER GENE; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0037438371     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1751     Document Type: Article

References (32)

1. Thomas ED, Blume KG, Forman SJ. Hematopoietic cell transplantation. 2nd ed. Malden, MA: Blackwell Science; 1999.
2. Kolb HJ, Mittermuller J, Clemm CH, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990;76:2462-2465.
3. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. Antileukemic effect of chronic graft versus host disease: contribution of improved survival after allogeneic marrow transplantation. N Engl J Med. 1981;304:1529-1533.
4. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods. 2000;243:147-154.
5. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. "Green mice" as a source of ubiquitous green cells. FEBS Lett. 1997;407:313-319.
6. Wilson T, Hastings JW. Bioluminescence. Annu Rev Cell Dev Biol. 1998;14:197-230.
7. Hastings JW. Chemistries and colors of bioluminescent reactions: a review. Gene. 1996;173:5-11.
8. Sweeney TJ, Mailander V, Tucker AA, et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A. 1999;96:12044-12049.
9. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol. 1995;18:593-603.
10. Contag PR, Olomu IN, Stevenson DK, Contag CH. Bioluminescent indicators in living mammals. Nat Med. 1998;4:245-247.
11. Edinger M, Sweeney TJ, Tucker AA, Olomu AB, Negrin RS, Contag CH. Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia. 1999;1:303-310.
12. Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J Immunol. 2000;164:3581-3590.
13. Robbins PB, Yu XJ, Skelton DM, et al. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol. 1997;71:9466-9474.
14. Eberl G, MacDonald HR. Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity. 1998;9:345-353.
15. Baker J, Verneris MR, Ito M, Shizuru JA, Negrin RS. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood. 2001;97:2923-2931.
16. Rice B, Cable M, Nelson M. In vivo imaging of light-emitting probes. J Biomed Opt. 2001;6:432-440.
17. Warnke RA, Slavin S, Coffman RL, et al. The pathology and homing of a transplantable murine B cell leukemia (BCL1). J Immunol. 1979;123:1181-1188.
18. Strober S, Gronowicz ES, Knapp MR, et al. Immunobiology of a spontaneous murine B cell leukemia (Bcl-1). Immunol Rev. 1979;48:169-195.
19. Lu PH, Negrin RS. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol. 1994;153:1687-1696.
20. Schmidt-Wolf IG, Negrin RS, Kiem HP, Blume KG, Weissman IL. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med. 1991;174:139-149.
21. Schmidt-Wolf IG, Lefterova P, Mehta BA, et al. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol. 1993;21:1673-1679.
22. Day RN, Kawecki M, Berry D. Dual-function reporter protein for analysis of gene expression in living cells. Biotechniques. 1998;25:848-850,852-844, 856.
23. Costa GL, Sandora MR, Nakajima A, et al. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol. 2001;167:2379-2387.
24. Resor L, Bowen TJ, Wynshaw-Boris A. Unraveling human cancer in the mouse: recent refinements to modeling and analysis. Hum Mol Genet. 2001;10:669-675.
25. Vooijs M, Jonkers J, Lyons S, Berns A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res. 2002;62:1862-1867.
26. Merrill JE, Murphy SP. Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain Behav Immun. 1997;11:245-263.
27. Verneris MR, Ito M, Baker J, Arshi A, Negrin RS, Shizuru JA. Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma. Biol Blood Marrow Transplant. 2001;7:532-542.
28. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol. 1999;72:209-253.
29. Klug CA, Cheshier S, Weissman IL. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny. Blood. 2000;96:894-901.
30. Halene S, Wang L, Cooper RM, Bockstoce DC, Robbins PB, Kohn DB. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood. 1999;94:3349-3357.
31. Stripecke R, Carmen Villacres M, Skelton D, Satake N, Halene S, Kohn D. Immune response to green fluorescent protein: implications for gene therapy. Gene Ther. 1999;6:1305-1312.
32. Gambotto A, Dworacki G, Cicinnati V, et al. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2 Kd-restricted CTL epitope. Gene Ther. 2000;7:2036-2040.